Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-3.07	74.20	76.56
Graham Fair Price	13.26	8.88	7.84
PEG	-43.78	0.87	-1.54
Price/Book	51.18	39.94	26.42
Price/Cash Flow	38.14	83.12	60.17
Prices/Earnings	-29.84	58.39	83.23
Price/Sales	35.74	25.98	19.14
Price/FCF	38.14	83.12	60.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.78	0.67	0.83
Operating Margin	-22.82	0.24	0.31
ROA	50.70	< 0.005	< 0.005
ROE	0.08	0.17	115.49
ROIC	0.04	0.03	-35.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.25	-0.02	998.53
Dividends QOQ	< 0.005	0.05	24460.21
EBIT QOQ	0.97	-0.34	-65.48
EPS QOQ	-0.54	0.67	24.80
FCF QOQ	-0.38	-0.15	59.61
Revenue QOQ	0.03	-0.14	418.43
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	154.61	93.59	-39.47
Days Sales Outstanding (DSO)	70.20	87.36	24.44
Inventory Turnover	0.58	0.96	65.20
Debt/Capitalization	0.85	0.90	5.98
Quick Ratio	0.63	0.72	14.12
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.87	4.53	-22.85
Cash	7.26	10.21	40.74
Capex	-0.12	-0.11	6.02
Free Cash Flow	2.58	2.17	-15.56
Revenue	8.10	6.96	-14.07
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.87	0.94	7.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.13	11.05	-0.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating